Vol. 19.Issue. 2. March - April 2020 | Annals of Hepatology

¿Aún no está registrado?

Información relevante

Consulte los artículos y contenidos publicados en éste medio, además de los e-sumarios de las revistas científicas en el mismo momento de publicación

Máxima actualización

Esté informado en todo momento gracias a las alertas y novedades

Promociones exclusivas

Acceda a promociones exclusivas en suscripciones, lanzamientos y cursos acreditados

Crear Mi cuenta

* = Required fields

Enter your email address

User name *

Annals of Hepatology

Buscar en

Annals of Hepatology

Toda la web

Inicio Annals of Hepatology

ISSN: 1665-2681

Annals of Hepatology (AoH) is an international, open access journal published bi-monthly with funds from the Fundación Clínica Médica Sur. It is the official journal of the Mexican Association of Hepatology (AMH), the Latin American Association for the Study of the Liver (ALEH), the Canadian Association for the Study of the Liver (CASL) and the Czech Society of Hepatology (CSH). AoH publishes editorials, opinions, concise reviews, original articles, brief reports, letters to the editor, news from affiliated associations, clinical practice guidelines and summaries of congresses in the field of Hepatology.

Topics covered by AoH include alcoholic liver disease, autoimmune hepatitis, biliary diseases, drug-induced liver injury, genetic liver diseases, NAFLD/NASH and viral hepatitis (HAV, HBV, HCV, HDV, HEV). Our journal seeks to publish articles on basic clinical care and translational research focused on preventing rather than treating the complications of end-stage liver disease.

See more Open Access Option

Indexed in:

Scopus, Web of Science, Medline/PubMed, DOAJ and Conacyt

See more

Follow us:

Impact factor

The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years.

© Clarivate Analytics, Journal Citation Reports 2022

See more

Impact factor 2022

3.8

Citescore

CiteScore measures average citations received per document published.

See more

Citescore 2022

6.3

SJR

SRJ is a prestige metric based on the idea that not all citations are the same. SJR uses a similar algorithm as the Google page rank; it provides a quantitative and qualitative measure of the journal's impact.

See more

SJR 2022

0.859

SNIP

SNIP measures contextual citation impact by wighting citations based on the total number of citations in a subject field.

See more

SNIP 2022

0.989

View more metrics

Journal Information

Previous Issue | Next Issue

Issue

Vol. 19. Issue 2.

Pages 119-226 (March - April 2020)

Editorial

Where is the focus on hepatitis C research after the introduction of DAAs: To Understand, knowledge, prevent or cure hepatitis C?

Ana M. Rivas-Estilla, Sonia A. Lozano-Sepulveda

Ann Hepatol. 2020;19:119-20

Open access

Opinions

Antiretroviral Therapies for Human Immunodeficiency Virus and Liver Disease: Challenges and opportunities

Julio C. Abarca, Leonor Huerta, Nora A. Fierro

Ann Hepatol. 2020;19:121-2

Open access

How far is Mexico from Viral Hepatitis Global Health Sector Strategy 2030 targets

Christian A. García-Sepúlveda, Saul Laguna-Meraz, Arturo Panduro

Ann Hepatol. 2020;19:123-5

Open access

Concise reviews

ABCB4 disease: Many faces of one gene deficiency

Eva Sticova, Milan Jirsa

Ann Hepatol. 2020;19:126-33

Open access

Chronic kidney disease in patients with non-alcoholic fatty liver disease: What the Hepatologist should know?

Stefania Kiapidou, Christina Liava, Maria Kalogirou, Evangelos Akriviadis, Emmanouil Sinakos

Ann Hepatol. 2020;19:134-44

Open access

Mechanisms of kidney dysfunction in the cirrhotic patient: Non-hepatorenal acute-on-chronic kidney damage considerations

María-Jimena Muciño-Bermejo

Ann Hepatol. 2020;19:145-52

Open access

Original articles

Hepatotoxicity during TB treatment in people with HIV/AIDS related to NAT2 polymorphisms in Pernambuco, Northeast Brazil

Carolline Araujo-Mariz, Maria de Fátima P. Militão de Albuquerque, Edmundo P. Lopes, Ricardo A.A. Ximenes, Heloísa R. Lacerda, Demócrito B. Miranda-Filho, Brena B. Lustosa-Martins, André Filipe P. Pastor, Bartolomeu Acioli-Santos

Ann Hepatol. 2020;19:153-60

Open access

HEPLA: A multicenter study on demographic and disease characteristics of patients with hepatitis C in Latin America

Luis Viola, Sebastian Marciano, Luis Colombato, Henrique Coelho, Hugo Cheinquer, Gabriela Bugarin, Fernando Tatsch, Roberto J. Carvalho-Filho, ... Alma M. Pérez-Ríos

Ann Hepatol. 2020;19:161-5

Open access

Comparative study of impulsiveness and risk behaviors among infected individuals with hepatitis C virus and human T-cell lymphotropic virus type 1

Ricardo Henrique-Araújo, Lucas C. Quarantini, Mychelle Morais-de-Jesus, Ana Paula Jesus-Nunes, Adriana Dantas-Duarte, André C. Caribé, Felipe C. Argolo, Roberta F. Marback, ... Irismar Reis de Oliveira

Ann Hepatol. 2020;19:166-71

Open access

EPA plus DHA improves survival related to a decrease of injury after extended liver ischemia in Sprague-Dawley rats

Nicole Céspedes, Andrea Tamayo, Maria Jose Rodriguez, Jessica Zúñiga-Hernández

Ann Hepatol. 2020;19:172-8

Open access

A combination of α-fetoprotein, midkine, thioredoxin and a metabolite for predicting hepatocellular carcinoma

Mohamed M. Omran, Khaled Farid, Mona A. Omar, Tarek M. Emran, Fathy M. El-Taweel, Ashraf A. Tabll

Ann Hepatol. 2020;19:179-85

Open access

Low prevalence of anti-hepatitis E virus IgG antibodies in Tepehuanos in Mexico

Cosme Alvarado-Esquivel, Verónica Dayali Gutierrez-Martinez, Eda Guadalupe Ramírez-Valles, Antonio Sifuentes-Alvarez

Ann Hepatol. 2020;19:186-9

Open access

Role of zinc supplementation in the management of chronic liver diseases: A systematic review and meta-analysis

Daniela C. Diglio, Sabrina A. Fernandes, Jessica Stein, André Azeredo-da-Silva, Angelo A. de Mattos, Cristiane V. Tovo

Ann Hepatol. 2020;19:190-6

Open access

Effects of hepatitis B virus infection, alanine aminotransferase, aspartate aminotransferase and gamma-glutamyl transferase on prediabetes and diabetes mellitus: A cohort study

Ting Gan, Ning Cheng, Jiao Ding, Zhiyuan Cheng, Desheng Zhang, Haiyan Li, Juansheng Li, Na Li, ... Yana Bai

Ann Hepatol. 2020;19:197-203

Open access

The relative expression of hepatocellular and cholestatic liver enzymes in adult patients with liver disease

Daniel Iluz-Freundlich, Manna Zhang, Julia Uhanova, Gerald Y. Minuk

Ann Hepatol. 2020;19:204-8

Open access

Validation of original, expanded Baveno VI, and stepwise & platelet-MELD criteria to rule out varices needing treatment in compensated cirrhosis from various etiologies

Siwanon Nawalerspanya, Pimsiri Sripongpun, Naichaya Chamroonkul, Chanon Kongkamol, Teerha Piratvisuth

Ann Hepatol. 2020;19:209-13

Open access

MicroRNA-124a contributes to glucocorticoid resistance in acute-on-chronic liver failure by negatively regulating glucocorticoid receptor alpha

Xin Wang, Hongrui Xu, Yadong Wang, Chuan Shen, Luyuan Ma, Caiyan Zhao

Ann Hepatol. 2020;19:214-21

Open access

Letters to the editor

Eradication of hepatitis C virus infection disclosing a previously hidden, underlying autoimmune hepatitis: Autoimmune hepatitis and HCV

Valentina Cacciato, Edoardo Casagrande, Giorgia Bodini, Manuele Furnari, Elisa Marabotto, Federica Grillo, Edoardo G. Giannini

Ann Hepatol. 2020;19:222-5

Open access